EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and rs2221903 Polymorphism

Noemí Espinoza-García, Diana Celeste Salazar-Camarena, Miguel Marín-Rosales iD, María Paulina Reyes-Mata iD, María Guadalupe Ramírez-Dueñas, José Francisco Muñoz-Valle, Itzel María Borunda-Calderón, Aarón González-Palacios iD, Claudia Azucena Palafox-Sánchez iD

Journal of Clinical Medicine · 02.08.2024 · 13 (15) · 4512

DOI: 10.3390/jcm13154512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.08.2024. Verfasst von Noemí Espinoza-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Ciencias en Biología Molecular en Medicina (DCBMM), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajar…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by Fondo de Desarrollo Científico de Jalisco para atender retos sociales "FODECIJAL 2023" grant to CAPS from Consejo Estatal de Cie…, Fondo de Desarrollo Científico de Jalisco para atender retos sociales “FODECIJAL 2023”, Fondos para Proyectos de Impulso a la Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and diverse tissue and organ inflammatory affections. Interleukin 21 (IL-21) is implicated in B cell survival, proliferation, differentiation, class switching, and immunoglobulin production; therefore, it is considered a key cytokine in the pathogenesis of SLE. However, its association with disease activity and clinical phenotypes remains unclear. We aimed to evaluate the association of IL-21 levels with the disease activity and clinical phenotypes in patients with SLE. Also, we analyzed the IL21 polymorphisms associated with increased IL-21 levels.

Methods

The IL-21 serum levels were determined using the enzyme-linked immunosorbent assay (ELISA) method. The rs2221903 and rs2055979 polymorphisms were assessed in 300 healthy controls (HCs) and 300 patients with SLE by the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) technique. The levels of IL-21 were monitored during follow-up visits in 59 patients with SLE.

Results

The patients with SLE showed higher IL-21 levels compared to the HCs. The IL-21 levels did not correlate with Mex-SLEDAI and were not different in patients with inactive, mild–moderate, and severe disease. The IL-21 levels were increased in patients with hematological affection. The ROC curve analysis revealed that the IL-21 levels had good predictive power in discriminating among patients with SLE and HCs. In a follow-up analysis, the levels of IL-21 remained higher in the patients with SLE even when the patients were in remission. Also, the rs2221903 polymorphism was associated with increased IL-21 levels.

Conclusions

This study highlights the importance of IL-21 as a key cytokine in SLE. IL-21 levels are higher in patients with SLE and remain increased regardless of disease activity. According to the ROC analysis, IL-21 is a potential biomarker of SLE. Further longitudinal studies are needed to explore the relationship between IL-21 and the clinical phenotypes of SLE.

Schlagwörter

Stichwörter der Autor:innen

IL21 polymorphismInterleukin 21systemic lupus erythematosus

Autor:innen und Institutionen

  • Doctorado en Ciencias en Biología Molecular en Medicina (DCBMM), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Grupo de Inmunología Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Hospital General de Occidente, Secretaría de Salud Jalisco, Guadalajara 45170, Jalisco, Mexico.
  • Instituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Doctorado en Ciencias Biomédicas (DCB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

ORCID-Profile: Miguel Marín-Rosales, María Paulina Reyes-Mata, Aarón González-Palacios, Claudia Azucena Palafox-Sánchez

Förderung

  • This research was supported by Fondo de Desarrollo Científico de Jalisco para atender retos sociales "FODECIJAL 2023" grant to CAPS from Consejo Estatal de Cie…
  • Fondo de Desarrollo Científico de Jalisco para atender retos sociales “FODECIJAL 2023”
  • Fondos para Proyectos de Impulso a la Investigación

Zitieren

APA

Espinoza-García, N., Salazar-Camarena, D. C., Marín-Rosales, M., Reyes-Mata, M. P., Ramírez-Dueñas, M. G., Muñoz-Valle, J. F., Borunda-Calderón, I. M., González-Palacios, A., & Palafox-Sánchez, C. A. (2024). High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and rs2221903 Polymorphism. Journal of Clinical Medicine, 13(15), 4512. https://doi.org/10.3390/jcm13154512

Vancouver

Espinoza-García N, Salazar-Camarena DC, Marín-Rosales M, Reyes-Mata MP, Ramírez-Dueñas MG, Muñoz-Valle JF, et al. High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and rs2221903 Polymorphism. Journal of Clinical Medicine. 2024;13(15):4512. doi:10.3390/jcm13154512

BibTeX
@article{EspinozaGarca2024,
  author = {Espinoza-García, Noemí and Salazar-Camarena, Diana Celeste and Marín-Rosales, Miguel and Reyes-Mata, María Paulina and Ramírez-Dueñas, María Guadalupe and Muñoz-Valle, José Francisco and Borunda-Calderón, Itzel María and González-Palacios, Aarón and Palafox-Sánchez, Claudia Azucena},
  title = {High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and rs2221903 Polymorphism},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {15},
  pages = {4512},
  doi = {10.3390/jcm13154512}
}
Kostenlos starten →